Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver-related mortality.

MLA

Srouji, Rami, et al. “Addition of Adjuvant Hepatic Artery Infusion to Systemic Chemotherapy Following Resection of Colorectal Liver Metastases Is Associated with Reduced Liver-Related Mortality.” Journal of Surgical Oncology, vol. 121, no. 8, June 2020, pp. 1314–19. EBSCOhost, https://doi.org/10.1002/jso.25916.

APA

Srouji, R., Narayan, R., Boerner, T., Buisman, F., Seier, K., Gonen, M., Balachandran, V. P., Drebin, J., Jarnagin, W. R., Kingham, T. P., Wei, A., Kemeny, N. E., & D’Angelica, M. (2020). Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver-related mortality. Journal of Surgical Oncology, 121(8), 1314–1319. https://doi.org/10.1002/jso.25916

Chicago

Srouji, Rami, Raja Narayan, Thomas Boerner, Florian Buisman, Ken Seier, Mithat Gonen, Vinod P Balachandran, et al. 2020. “Addition of Adjuvant Hepatic Artery Infusion to Systemic Chemotherapy Following Resection of Colorectal Liver Metastases Is Associated with Reduced Liver-Related Mortality.” Journal of Surgical Oncology 121 (8): 1314–19. doi:10.1002/jso.25916.